THNR
Amplify Weight Loss Drug & Treatment ETF
$26.69
$-0.27 (-1.02%)
Delayed ≥20 min · Aug 31, 2026
Key Statistics
Net Assets (AUM)
-
Expense Ratio
See prospectus
Previous Close
$26.96
Day Range
- – -
52-Week Range
$22.63 – $27.94
Volume
439
Avg Vol (50D)
-
Beta
0.37
Historical Performance
1M
+5.09%
3M
+9.99%
6M
+4.21%
YTD
+5.82%
1Y
+18.31%
3Y
—
5Y
—
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
Detailed holdings are compiled from each fund’s latest SEC N-PORT portfolio filing.
THNR News
- (THNR) Price Dynamics and Execution-Aware Positioning
- (THNR) as a Liquidity Pulse for Institutional Tactics
- Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) Short Interest Down 33.4% in July
- (THNR) Risk Channels and Responsive Allocation
- (THNR) Risk Channels and Responsive Allocation
- (THNR) Movement as an Input in Quant Signal Sets
- Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
- Short Interest in Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) Grows By 330.5%
- Liquidity Mapping Around (THNR) Price Events
- Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
Data for THNR is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.